openPR Logo
Press release

Platelet Rich Plasma (PRP) Market Trends and Opportunities for the Industry by 2024

03-24-2017 02:16 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Platelet Rich Plasma (PRP) Market Trends and Opportunities

With a larger pool of players operating domestically and a smaller bunch of international participants, the global platelet-rich plasma (PRP) market demonstrates a semi-consolidated landscape. The top five players, namely, Harvest Technologies, Arthrex Inc., Zimmer Biomet, DePuy Synthes, and Stryker Corp. accounted for more than 80% of this market in 2015. Most of these are headquartered in North America. However, their focus is likely to shift towards emerging economies across Asia Pacific in the coming years, as this region is expected to offer lucrative opportunities on account of untapped potential.

Obtain Report Details @ http://www.transparencymarketresearch.com/platelet-rich-plasma-market.html

As per the research study, the global market for PRP, which was valued at US$160.0 mn in 2015, is likely to expand at a CAGR of 12.50% during the period from 2016 to 2024 and report an opportunity worth US$451.9 mn by the end of the forecast period. The P-PRP segment, which occupied more than 60% of the overall market in 2015, is expected to remain leading throughout the forecast period.

Wide Presence of Leading Players to Ensure North America’s Dominance

The research report has also evaluated the global market for PRP on the basis of its geographical spread. It has identified North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America as the key regional markets for PRP across the world. Supported by the increasing count of orthopedic and cosmetic surgeries, North America led the global market with a majority share in 2015. Further, the wide presence of leading market players and the high awareness level among consumers about PRP therapy and devices are likely to ensure the leadership of this regional market throughout the forecast period.

Asia Pacific is also expected to witness a healthy rise in the adoption of PRP therapies in the near future. The swiftly growing medical tourism industry, presence of well-established local players, increased base of the geriatric population, and the rising awareness regarding PRP among people are projected to boost the Asia Pacific PRP market over the forthcoming years, states the research report.

Increasing Count of Orthopedic Patients to Fuel Demand

“The significant increase in the count of orthopedic patients, worldwide, is the prime factor behind the tremendous progress of the global PRP market,” says a TMR analyst. As PRP therapy curtails the healing time of orthopedic or sports injuries from 4-6 months to 3-5 weeks with surgery, its demand for the treatment of orthopedic surgeries has increased remarkably and this is likely to remain so over the next few years.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4021

The rise in cosmetic surgical procedures is another important factor that is likely to shape the future of the global PRP market. The high cost of PRP products and therapy is expected to hamper the growth of this market to some extent during the forecast period, notes the research study.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Platelet Rich Plasma (PRP) Market Trends and Opportunities for the Industry by 2024 here

News-ID: 481533 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for PRP

Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Global Platelet Rich Plasma (PRP) Industry
Global Platelet Rich Plasma (PRP) Industry Global PRP market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Harvest Technologies DePuy Synthes Stryker Zimmer Biomet Arthrex Exactech Emcyte Corporation Arteriocyte Adilyfe Try Sample Report @ https://www.wiseguyreports.com/sample-request/1140003-global-prp-market-research-report-2017 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of PRP in
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.
Competitive Landscape for PRP Market Key Trends 2024
Global Platelet Rich Plasma (PRP) Market: Snapshot Of late, the global market for platelet rich plasma (PRP) has been witnessing a remarkable rise in its valuation. The upswing in the incidence of orthopedic diseases, propelled by the increasing cases of sports injuries, and the growing prevalence of cardiothoracic and neurological disorders has emerged as the main factor behind this tremendous growth of this market. In addition to this, the surge in cosmetic